Study #2020-0662
The impact of COVID-19 on pulmonary procedures: a nationwide survey
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
COVID-19 Infection;Hematopoietic and Lymphoid Cell Neoplasm;Malignant Solid Neoplasm
Study phase:
Physician name:
Bruce Sabath
Department:
Pulmonary Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.